Wave Life Sciences Ltd. (NASDAQ: WVE) kicked off on Monday, up 3.74% from the previous trading day, before settling in for the closing price of $14.45. Over the past 52 weeks, WVE has traded in a range of $3.50-$15.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 610.91%. While this was happening, its average annual earnings per share was recorded -87.66%. With a float of $120.28 million, this company’s outstanding shares have now reached $154.93 million.
Let’s determine the extent of company efficiency that accounts for 268 employees. In terms of profitability, gross margin is 92.04%, operating margin of -75.74%, and the pretax margin is -67.11%.
Wave Life Sciences Ltd. (WVE) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd. is 22.36%, while institutional ownership is 65.33%. The most recent insider transaction that took place on Oct 16 ’24, was worth 2,855,051. In this transaction an insider of this company sold 208,836 shares at a rate of $13.67, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 16 ’24, when Company’s President and CEO sold 90,474 for $15.00, making the entire transaction worth $1,357,110. This insider now owns 268,585 shares in total.
Wave Life Sciences Ltd. (WVE) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.07 earnings per share (EPS), higher than consensus estimate (set at -0.18) by 0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -87.66% per share during the next fiscal year.
Wave Life Sciences Ltd. (NASDAQ: WVE) Trading Performance Indicators
Take a look at Wave Life Sciences Ltd.’s (WVE) current performance indicators. Last quarter, stock had a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd. (WVE)
Looking closely at Wave Life Sciences Ltd. (NASDAQ: WVE), its last 5-days average volume was 1.27 million, which is a jump from its year-to-date volume of 1.1 million. As of the previous 9 days, the stock’s Stochastic %D was 80.59%. Additionally, its Average True Range was 0.94.
During the past 100 days, Wave Life Sciences Ltd.’s (WVE) raw stochastic average was set at 92.03%, which indicates a significant increase from 88.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 226.48% in the past 14 days, which was higher than the 130.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.20, while its 200-day Moving Average is $6.16. However, in the short run, Wave Life Sciences Ltd.’s stock first resistance to watch stands at $15.24. Second resistance stands at $15.50. The third major resistance level sits at $15.86. If the price goes on to break the first support level at $14.62, it is likely to go to the next support level at $14.26. Should the price break the second support level, the third support level stands at $14.00.
Wave Life Sciences Ltd. (NASDAQ: WVE) Key Stats
The company with the Market Capitalisation of 2.32 billion has total of 122,475K Shares Outstanding. Its annual sales at the moment are 113,310 K in contrast with the sum of -57,510 K annual income. Company’s last quarter sales were recorded 19,690 K and last quarter income was -32,920 K.
